The role of infectious agents in urogenital cancers

Infectious Agents and Cancer

Volumn 7, Issue 1, 2012, Pages

  Alibek, Kenneth ^a,b   Karatayeva, Nargis ^a   Bekniyazov, Ildar ^a  

^a NAZARBAYEV UNIVERSITY   (Kazakhstan)

^b Republican Scientific Center for Emergency Care   (Kazakhstan)

Author keywords

Bladder cancer; Cervical cancer; Chlamydia trachomatis; CMV; Epstein Barr; HPV; Human polyomaviruses; Kidney cancer; Mycoplasma genitalium; Neisseria gonorrhea; Ovarian cancer; Schistosoma haematobium; Urogenital cancers

Indexed keywords

BLADDER CANCER; CARCINOGENESIS; CHLAMYDIA TRACHOMATIS; EPSTEIN BARR VIRUS; HEPATITIS C VIRUS; HUMAN; KIDNEY CANCER; MYCOPLASMA GENITALIUM; NEISSERIA GONORRHOEAE; OVARY CANCER; POLYOMA VIRUS; PRIORITY JOURNAL; REVIEW; SCHISTOSOMA HEMATOBIUM; UROGENITAL TRACT CANCER; UTERINE CERVIX CANCER; WART VIRUS;

EID: 84870300128     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-7-35     Document Type: Review

References (73)

1. Cancer and infection: estimates of the attributable fraction in 1990. Pisani P, Parkin DM, Muñoz N, Ferlay J, Cancer Epidemiol Biomarkers Prev 1997 6 6 387 400 9184771
2. Worldwide burden of gynaecological cancer: the size of the problem. Sankaranarayanan R, Ferlay J, Best Pract Res Clin Obstet Gynaecol 2006 20 2 207 225 10.1016/j.bpobgyn.2005.10.007 16359925
3. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, Int J Cancer 2010 127 12 2893 2917 10.1002/ijc.25516 21351269
4. The rational treatment of cancer. Weinberg RA, The biology of cancer LLC: Taylor & Francis Group, Garland Science, 1 2007 725 795
5. Ovarian carcinogenesis: an alternative hypothesis. Piek JM, van Diest PJ, Verheijen RH, Adv Exp Med Bio 2008 622 79 87 10.1007/978-0-387-68969-2-7
6. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Riman T, Nilsson S, Persson IR, Acta Obstet Gynecol Scand 2004 83 9 783 795 15315588
7. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Lukanova A, Kaaks R, Cancer Epidemiol Biomarkers Prev 2005 14 1 98 107 15668482
8. Possible role of ovarian epithelial inflammation in ovarian cancer. Ness RB, Cottreau C, J Natl Cancer Inst 1999 91 17 1459 1467 Review. PubMed PMID: 10469746 10.1093/jnci/91.17.1459 10469746
9. Occupational exposure to asbestos and ovarian cancer: a meta-analysis. Camargo MC, Stayner LT, Straif K, Reina M, Al-Alem U, Demers PA, Landrigan PJ, Environ Health Perspect 2011 119 9 1211 1217 Epub 2011 Jun 3 10.1289/ehp.1003283 21642044
10. Does exposure to asbestos cause ovarian cancer? A systematic literature review and meta-analysis. Reid A, de Klerk N, Musk AW, Cancer Epidemiol Biomarkers Prev 2011 20 7 1287 1295 Epub 2011 May 24 10.1158/1055-9965.EPI-10- 1302 21610219
11. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Munksgaard PS, Blaakaer J, Gynecol Oncol 2012 124 1 164 169 Epub 2011 Oct 26 10.1016/j.ygyno.2011.10.001 22032835
12. Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Sainz de la Cuesta R, Eichhorn JH, Rice LW, Fuller AF Jr, Mikrui N, Goff BA, Gynecol Oncol 1996 60 238 244 10.1006/gyno.1996.0032 8631545
13. Prevalence of ovarian endometriosis in epithelial ovarian cancer. Jimbo H, Yoshikawa H, Onda T, Yasugi T, Sakamoto A, Taketani Y, Int J Gynecol Obstet 1997 59 245 250 10.1016/S0020-7292(97)00238-5
14. Endometrioid carcinoma of the ovary and endometriosis: the association in postmenopausal women. DePriest PD, Banks ER, Powell DE, van Nagell JR, Gallion Jr HH, Puls SE, Gynecol Oncol 1992 47 71 75 10.1016/0090-8258(92)90079-X 1427405
15. Tubal ligation, hysterectomy and ovarian cancer: a meta-analysis. Rice MS, Murphy MA, Tworoger SS, J Ovarian Res. 2012 5 1 13 10.1186/1757-2215-5-13 22587442
16. Population-based case-control study of ovarian cancer in Shanghai. Shu XO, Brinton LA, Gao YT, Yuan JM, Cancer Res 1989 49 3670 3674 2731180
17. Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Risch HA, Howe GR, Cancer Epidemiol Biomarkers Prev 1995 4 447 451 7549798
18. Why cancer and inflammation? Rakoff-Nahoum S, Yale J Biol Med 2006 79 3-4 123 130 17940622
19. Radical causes of cancer. Hussain SP, Hofseth LJ, Harris CC, Nat Rev Cancer 2003 3 4 276 285 10.1038/nrc1046 12671666
20. Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis. Greene W, Xiao Y, Huang Y, McClarty G, Zhong G, Infect Immun 2004 72 1 451 460 10.1128/IAI.72.1.451-460.2004 14688126
21. Human papillomaviruses. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, IARC Monogr Eval Carcinog Risks Hum 2007 90 1 636 18354839
22. Chlamydia trachomatis and cancer. Paavonen J, Sex Transm Infect 2001 77 154 156 10.1136/sti.77.3.154 11402220
23. Chlamydia trachomatis and mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors. Idahl A, Lundin E, Jurstrand M, Kumlin U, Elgh F, Ohlson N, Ottander U, Infect Dis Obstet Gynecol 2011 2011 824627 Published online 2011 July 28 21811380
24. Sexually transmitted diseases. Goering RV, Mims' Medical Microbiology Elsevier Limited, Goering R, Dockrell H, Roitt I, Zuckerman M, Wakelin D, 1 2003 261 285 23571385
25. Restricted fusion of Chlamydia trachomatis vesicles with endocytic compartments during the initial stages of infection. Scidmore MA, Fischer ER, Hackstadt T, Infect Immun 2003 71 2 973 984 10.1128/IAI.71.2.973-984.2003 12540580
26. Mapping antigenic sites on the major outer membrane protein of Chlamydia trachomatis with synthetic peptides. Zhong GM, Reid RE, Brunham RC, Infect Immun 1990 58 5 1450 1455 1691149
27. Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. Zhong G, Fan T, Liu L, J Exp Med 1999 189 12 1931 1938 10.1084/jem.189.12.1931 10377188
28. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells. Zhong G, Liu L, Fan T, Fan P, Ji H, J Exp Med 2000 191 9 1525 1534 10.1084/jem.191.9.1525 10790427
29. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. Zhong G, Fan P, Ji H, Dong F, Huang Y, J Exp Med 2001 193 8 935 942 10.1084/jem.193.8.935 11304554
30. Persistent Chlamydia trachomatis infections resist apoptotic stimuli. Dean D, Powers VC, Infect Immun 2001 69 4 2442 2447 10.1128/IAI.69.4.2442-2447. 2001 11254605
31. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Beatty WL, Byrne GI, Morrison RP, Proc Natl Acad Sci USA 1993 90 9 3998 4002 10.1073/pnas.90.9.3998 8387206
32. Tubal factor infertilityis associated with antibodies against Chlamydia trachomatis heat shock protein 60 (HSP60) but not human HSP60. Hjelholt A, Christiansen G, Johannesson TG, Ingerslev HJ, Birkelund S, Hum Reprod 2011 26 8 2069 2076 10.1093/humrep/der167 21642639
33. Chlamydia trachomatis infection of human fallopian tube organ cultures. Cooper MD, Rapp J, Jeffery-Wiseman C, Barnes RC, Stephens DS, J Gen Microbiol 1990 136 6 1109 1115 2384745
34. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Belland RJ, Scidmore MA, Crane DD, Hogan DM, Whitmire W, McClarty G, Caldwell HD, Proc Natl Acad Sci USA 2001 98 24 13984 13989 10.1073/pnas.241377698 11707582
35. Morphology of human Fallopian tubes after infection with Mycoplasma genitalium and Mycoplasma hominis-in vitro organ culture study. Baczynska A, Funch P, Fedder J, Knudsen HJ, Birkelund S, Christiansen G, Hum Reprod 2007 22 4 968 979 10.1093/humrep/del455 17158214
36. Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma. Jazaeri AA, Bryant JL, Park H, Li H, Dahiya N, Stoler MH, Ferriss JS, Dutta A, Neoplasia 2011 13 10 899 911 22028616
37. Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells. Namiki K, Goodison S, Porvasnik S, Allan RW, Iczkowski KA, Urbanek C, Reyes L, Sakamoto N, Rosser CJ, PLoS One 2009 4 9 6872 10.1371/journal.pone.0006872 19721714
38. Neisseria gonorrhoeae infection causes a G1 arrest in human epithelial cells. Jones A, Jonsson AB, Aro H, FASEB J 2007 21 2 345 355 10.1096/fj.06-6675com 17158783
39. Neisseria gonorrhoeae infection induces altered amphiregulin processing and release. Löfmark S, de Klerk N, Aro H, PLoS One 2011 6 1 16369 10.1371/journal.pone.0016369 21298020
40. The multiple roles of amphiregulin in human cancer. Busser B, Sancey L, Brambilla E, Coll JL, Hurbin A, Biochim Biophys Acta 2011 1816 2 119 131 21658434
41. Viral and bacterial aetiologies of epithelial ovarian cancer. Shanmughapriya S, Senthilkumar G, Vinodhini K, Das BC, Vasanthi N, Natarajaseenivasan K, Eur J Clin Microbiol Infect Dis 2012 [Epub ahead of print]
42. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Michaelis M, Doerr HW, Cinatl J Jr, Neoplasia 2009 11 1 1 9 19107226
43. HPV and cancer. National Cancer Institute 2012 [online] Available at: http://www.cancer.gov/cancertopics/factsheet/Risk/HPV#r5 [Accessed 17 September 2012]
44. Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Lehtinen M, Ault KA, Lyytikainen E, Dillner J, Garland SM, Ferris DG, Koutsky LA, Sings HL, Lu S, Haupt RM, Paavonen J, FUTURE I and II Study Group, Sex Transm Infect 2011 87 5 372 376 10.1136/sti.2010.044354 21471141
45. Epstein-Barr virus (EBV) genes expression in cervical intraepithelial neoplasia and invasive cervical cancer: a comparative study with human papillomavirus (HPV) infection. Sasagawa T, Shimakage M, Nakamura M, Sakaike J, Ishikawa H, Inoue M, Hum Pathol 2000 31 3 318 326 10.1016/S0046-8177(00)80245-2 10746674
46. Detection of Epstein-Barr virus-determined nuclear antigen-2 mRNA by in situ hybridization. Shimakage M, Sasagawa T, J Virol Methods 2001 93 1-2 23 32 11311340
47. Detection of Epstein-Barr Virus Nuclear Antigen Leader Protein Expression in Various Human Cancers. Shimakage M, Harada S, Kawahara K, New Developments in Epstein-Barr Virus Research Chapter XI Nova Science Publishers, Umar CS, 2006 261 276
48. Persistence of type-specific human papillomavirus infection among cytologically normal women. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, J Infect Dis 1994 169 2 235 240 10.1093/infdis/169.2.235 8106758
49. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Wacholder S, Tarone R, Burk RD, J Infect Dis 2005 191 11 1808 1816 10.1086/428779 15871112
50. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, Papp JR, Black CM, Unger ER, Am J Epidemiol 2005 162 7 668 675 10.1093/aje/kwi262 16120706
51. Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women. Shew ML, Fortenberry JD, Tu W, Juliar BE, Batteiger BE, Qadadri B, Brown DR, Arch Pediatr Adolesc Med 2006 160 2 151 156 10.1001/archpedi.160.2.151 16461870
52. Human papillomavirus (HPV) and Epstein-Barr virus (EBV) cervical infections in women with normal and abnormal cytology. Szkaradkiewicz A, Wal M, Kuch A, Pieta P, Pol J Microbiol 2004 53 2 95 99 15478354
53. Risk for renal cell carcinoma in chronic hepatitis C infection. Gordon SC, Moonka D, Brown KA, Rogers C, Huang MA, Bhatt N, Lamerato L, Cancer Epidemiol Biomarkers Prev 2010 19 4 1066 1073 10.1158/1055-9965.EPI-09-1275 20332260
54. Role of viruses in renal cell carcinoma. Salehipoor M, Khezri A, Behzad-Behbahani A, Geramizadeh B, Rahsaz M, Aghdaei M, Afrasiabi MA, Saudi J Kidney Dis Transpl 2012 23 1 53 57 22237219
55. Expression of Epstein-Barr virus in renal cell carcinoma. Shimakage M, Kawahara K, Harada S, Sasagawa T, Shinka T, Oka T, Oncol Rep 2007 18 41 46 17549343
56. History of urinary tract infection and risk of renal cell carcinoma. Parker A, Cerhan J, Lynch C, Leibovich B, Cantor K, Am J Epidemiol 2004 159 42 48 10.1093/aje/kwh014 14693658
57. American Cancer Society, Global Cancer Facts & Figures Atlanta: American Cancer Society 2 2011 22587022
58. Helminthes in human carcinogenesis. Fried B, Reddy A, Mayer D, Cancer Lett 2011 305 239 249 10.1016/j.canlet.2010.07.008 20667649
59. IARC, Monograph on the evaluation of carcinogenic risks to humans: schistosomes, liver flukes and Helicobacter pylori. Volume 61 WHO: International Agency for Research on Cancer 1994 9 175
60. Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Bedwani R, Renganathan E, El Kwhsky F, Braga C, Abu Seif HH, Abul Azm T, Zaki A, Franceschi S, Boffetta P, La Vecchia C, Br J Cancer 1998 77 7 1186 1189 10.1038/bjc.1998.197 9569060
61. Human papillomavirus infection and bladder cancer risk: a meta-analysis. Li N, Yang L, Zhang Y, Zhao P, Zheng T, Dai M, J Infect Dis 2011 204 2 217 223 10.1093/infdis/jir248 21673031
62. Condyloma acuminata of the urinary bladder. Natural history, viral typing, and DNA content. Del Mistro A, Koss LG, Braunstein J, Bennett B, Saccomano G, Simons KM, Am J Surg Pathol 1988 12 3 205 215 10.1097/00000478- 198803000-00006 2830802
63. Presence of human papillomavirus type 16 genome in bladder carcinoma in situ of a patient with mild immunodeficiency. Kitamura T, Yogo Y, Ueki T, Murakami S, Aso Y, Cancer Res 1988 48 24 Pt 1 7207 7211 2847865
64. Development of bladder tumor containing HPV type 11 DNA after renal transplantation. Querci della Rovere G, Oliver RT, McCance DJ, Castro JE, Br J Urol 1988 62 1 36 38 10.1111/j.1464-410X.1988.tb04261.x 2841992
65. Oncogenic human papillomaviruses are rarely associated with squamous cell carcinoma of the bladder: evaluation by differential polymerase chain reaction. Maloney KE, Wiener JS, Walther PJ, J Urol 1994 151 2 360 364 8283525
66. Correlation between human papillomavirus infection and bladder transitional cell carcinoma. Barghi MR, Hajimohammadmehdiarbab A, Moghaddam SM, Kazemi B, BMC Infect Dis 2005 5 102 10.1186/1471-2334-5-102 16274490
67. Human papillomavirus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Moonen PM, Bakkers JM, Kiemeney LA, Schalken JA, Melchers WJ, Witjes JA, Eur Urol 2008 53 4 858 859 10.1016/j.eururo.2007.09.041 17920185
68. Immunohistochemical characteristics and a degree of differentiation of urinary bladder cancer. Frank GA, Zavalishina LE, Andreeva l, Arkh Patol 2002 64 6 16 18 15338718
69. Volgareva G, Trofimova O, Kuevda D, Zavalishina L, Golovina D, Andreeva Y, Ermilova V, Cheban N, Glazunova V, Matvejev V, Shipulina O, Frank G, HPV and urinary bladder cancer. Proceedings of the 25-th International Papillomavirus Conference Malmo, Sweden 2009 -18.42
70. Low frequency of human polyomavirus BKV and JCV DNA in urothelial carcinomas of the renal pelvis and renal cell carcinomas. Knöll A, Stoehr R, Jilg W, Hartmann A, Oncol Rep 2003 10 2 487 491 12579294
71. BK virus and human cancer: innocent until proven guilty. Abend JR, Jiang M, Imperiale MJ, Semin Cancer Biol 2009 19 4 252 260 10.1016/j.semcancer.2009. 02.004 19505653
72. The high incidence of JC virus infection in urothelial carcinoma tissue in Taiwan. Shen C, Wu J, Hsu C, Jou Y, Lin C, Wang M, Wu S, Chan M, Chiang M, Fang C, Chang D, J Med Virol 2011 83 12 2191 2199 10.1002/jmv.22240 22012728
73. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Geetha D, Tong BC, Racusen L, Markowitz JS, Westra WH, Transplantation 2002 73 12 1933 1936 10.1097/00007890-200206270-00015 12131691